A GWAS meta-analysis involving hundreds of thousands of cases and controls led to new and known gallstone disease-associated variants at 28 loci.
The new entity will offer comprehensive genomic services for precision medicine and drug discovery for central nervous system diseases.
The company is developing a single-molecule sequencing technology intended to significantly reduce the cost and improve the accuracy of sequencing.
Researchers from Peking University used their method, called scTrio-seq2, to characterize and trace genetic lineages of colorectal cancer cells.
Respondents to GenomeWeb's salary survey reported variations in their salaries that varied by sector.
The researchers reported that targeting HDAC4 in the patient-derived neurons appeared to correct the expression of genes that differed in the disease state.
With a DNA methylation atlas and deconvolution algorithm, researchers are attempting to trace cfDNA back to tissue sources in healthy or ill individuals.
Karius said it will use the money to continue commercialization of its diagnostic technologies and to fund clinical studies, among other things.
The firms will begin a prospective lung cancer study using Biocartis' Idylla EGFR mutation test in European countries, including Belgium, France, Germany, and Italy.
The companies have agreed to distribute and codevelop diagnostics for the transplant monitoring market.
In an SEC filing, the company proposed to sell shares of its stock, each coupled with a warrant to purchase up to one additional share.
The LeukoStrat CDx FLT3 Mutation Assay is a PCR-based test for internal tandem duplications and tyrosine kinase domain mutations D835 and I836 in the FLT3 gene.
Signature Science will assess the validity of metagenomic and metatranscriptomic analyses to detect the transmission of viable pathogens in healthcare settings.
Prospective research suggests DNA and RNA sequencing can reveal pathogen, microbiome, and host expression features to detect lower respiratory tract infections.
CNGB was founded by the Chinese government and BGI to collect genomics technologies and resources, and promote their use by the research community.
The firms said they will integrate their capabilities and competencies to offer solutions to global pharmaceutical customers.
A circulating tumor DNA analysis identified somatic mutations in more than 64 percent of advanced non-small cell lung cancer cases, including some drug targets.
Australian Clinical Labs will take over the the clinical pathology and reporting responsibilities of Garvan Institute of Medical Research subsidiary Genome.One.
An international team of researchers used ancient and modern genome sequences to examine the admixture and population history of Finland.
The researchers studied edits generated by more than 40,000 gRNAs and gathered data for more than 109 mutational outcomes to create the software.
The test is the first whole-genome-based cancer test to receive approval from New York State's Department of Health.
The university will use the technology to screen blood samples for certain clinically actionable mutations in non-small cell lung cancer patients.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.